Rapport Therapeutics Expects Cash to Fund Requirements Through 2026

Yahoo Finance20:18

TD Cowen Maintains Rapport Therapeutics(RAPP.US) With Buy Rating

Futu News01:31 · Ratings

Rapport Therapeutics, Inc. (RAPP) Gets a Buy From TD Cowen

TipRanks00:56 · Ratings

Express News | Rapport Therapeutics Inc Q3 Shr View $-0.58 -- LSEG IBES Data

BreakingsNov 7 20:15

Rapport Therapeutics 3Q Loss/Shr 50c >RAPP

Dow JonesNov 7 20:05

Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update

GlobeNewswireNov 7 20:00